BioElectronics Corporation Announces US FDA OTC Cl
Post# of 617763
FREDERICK, MD--(Marketwired - Feb 6, 2017) - BioElectronics Corporation (
BioElectronics is an electroceutical company that develops wearable, neuromodulation devices to safely mitigate neurological diseases and improve quality of life. Our innovative pulsed shortwave therapy technology (PSWT) that uses low power pulsed electromagnetic fields regulate electrical activity of the nervous system. The neuromodulation basis of PSWT presents significant opportunities for BioElectronics to develop optimized technology for diabetic neuropathy, postoperative surgery, chronic wounds, and other applications.
Our current OTC product line includes ActiPatch® Musculoskeletal Pain Therapy, Allay® Menstrual Pain Therapy, Smart Insole™ Heel Pain Therapy, and RecoveryRx® Post-operative and Chronic Wounds Therapy. The US FDA clearance is for our flagship product the ActiPatch® Musculoskeletal Pain Therapy, developed to relieve chronic pain. ActiPatch is a drug-free, wearable nonprescription medical device that provides 720-hours (90, 8-hour treatments) of on/off therapy for $30.00 retail. Most users obtain relief with only 8 hours per day of use, so the device will generally last several months, depending on use. ActiPatch Provides:
- Impressive Efficacy
- No harmful side effects
- A 50% Reduction in Medication Use, including opioids
- Exceptional Consumer Acceptance
- Demonstrated Marketability
- An adjunctive or alternative therapy to pain killers, including narcotics
About BioElectronics Corporation
BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: For more information, please visit www.bielcorp.com .
How to Order an ActiPatch®?
Visit tryactipatch.com to place your order for the ActiPatch ® today.
BioElectronics Corporation 301-874-4980 info@bielcorp.com 4539 Metropolitan Court Frederick, MD 21704